These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8429821)

  • 21. Selective inhibition of M
    Gunter BW; Gould RW; Bubser M; McGowan KM; Lindsley CW; Jones CK
    Addict Biol; 2018 Sep; 23(5):1106-1116. PubMed ID: 29044937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accumbal Cholinergic Interneurons Differentially Influence Motivation Related to Satiety Signaling.
    Aitta-Aho T; Phillips BU; Pappa E; Hay YA; Harnischfeger F; Heath CJ; Saksida LM; Bussey TJ; Apergis-Schoute J
    eNeuro; 2017; 4(2):. PubMed ID: 28497110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer's Disease.
    Ahmed T; Zahid S; Mahboob A; Farhat SM
    Curr Neuropharmacol; 2017; 15(4):480-494. PubMed ID: 27012953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.
    Gonzales KK; Smith Y
    Ann N Y Acad Sci; 2015 Sep; 1349(1):1-45. PubMed ID: 25876458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further optimization of the M5 NAM MLPCN probe ML375: tactics and challenges.
    Kurata H; Gentry PR; Kokubo M; Cho HP; Bridges TM; Niswender CM; Byers FW; Wood MR; Daniels JS; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2015 Feb; 25(3):690-4. PubMed ID: 25542588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Striatal cholinergic interneuron regulation and circuit effects.
    Lim SA; Kang UJ; McGehee DS
    Front Synaptic Neurosci; 2014; 6():22. PubMed ID: 25374536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery, synthesis and characterization of a highly muscarinic acetylcholine receptor (mAChR)-selective M5-orthosteric antagonist, VU0488130 (ML381): a novel molecular probe.
    Gentry PR; Kokubo M; Bridges TM; Cho HP; Smith E; Chase P; Hodder PS; Utley TJ; Rajapakse A; Byers F; Niswender CM; Morrison RD; Daniels JS; Wood MR; Conn PJ; Lindsley CW
    ChemMedChem; 2014 Aug; 9(8):1677-82. PubMed ID: 24692176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. M5 receptor activation produces opposing physiological outcomes in dopamine neurons depending on the receptor's location.
    Foster DJ; Gentry PR; Lizardi-Ortiz JE; Bridges TM; Wood MR; Niswender CM; Sulzer D; Lindsley CW; Xiang Z; Conn PJ
    J Neurosci; 2014 Feb; 34(9):3253-62. PubMed ID: 24573284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced nicotinic receptor mediated relaxations in gastroesophageal muscle fibers from Barrett's esophagus patients.
    Miller LS; Vegesna AK; Braverman AS; Barbe MF; Ruggieri MR
    Neurogastroenterol Motil; 2014 Mar; 26(3):430-9. PubMed ID: 24330081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375).
    Gentry PR; Kokubo M; Bridges TM; Kett NR; Harp JM; Cho HP; Smith E; Chase P; Hodder PS; Niswender CM; Daniels JS; Conn PJ; Wood MR; Lindsley CW
    J Med Chem; 2013 Nov; 56(22):9351-5. PubMed ID: 24164599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased noradrenaline levels in the rostral pons can be reversed by M1 antagonist in a rat model of post-traumatic stress disorder.
    Terzioğlu B; Kaleli M; Aydın B; Ketenci S; Cabadak H; Gören MZ
    Neurochem Res; 2013 Aug; 38(8):1726-33. PubMed ID: 23681605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholinergic connectivity: it's implications for psychiatric disorders.
    Scarr E; Gibbons AS; Neo J; Udawela M; Dean B
    Front Cell Neurosci; 2013; 7():55. PubMed ID: 23653591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of ML326: The first sub-micromolar, selective M5 PAM.
    Gentry PR; Bridges TM; Lamsal A; Vinson PN; Smith E; Chase P; Hodder PS; Engers JL; Niswender CM; Daniels JS; Conn PJ; Wood MR; Lindsley CW
    Bioorg Med Chem Lett; 2013 May; 23(10):2996-3000. PubMed ID: 23562060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.
    Zheng G; Smith AM; Huang X; Subramanian KL; Siripurapu KB; Deaciuc A; Zhan CG; Dwoskin LP
    J Med Chem; 2013 Feb; 56(4):1693-703. PubMed ID: 23379472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging approaches for treatment of schizophrenia: modulation of cholinergic signaling.
    Foster DJ; Jones CK; Conn PJ
    Discov Med; 2012 Dec; 14(79):413-20. PubMed ID: 23272693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockouts reveal overlapping functions of M(2) and M(4) muscarinic receptors and evidence for a local glutamatergic circuit within the laterodorsal tegmental nucleus.
    Kohlmeier KA; Ishibashi M; Wess J; Bickford ME; Leonard CS
    J Neurophysiol; 2012 Nov; 108(10):2751-66. PubMed ID: 22956788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An allosteric enhancer of M₄ muscarinic acetylcholine receptor function inhibits behavioral and neurochemical effects of cocaine.
    Dencker D; Weikop P; Sørensen G; Woldbye DP; Wörtwein G; Wess J; Fink-Jensen A
    Psychopharmacology (Berl); 2012 Nov; 224(2):277-87. PubMed ID: 22648127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. M4 muscarinic receptor knockout mice display abnormal social behavior and decreased prepulse inhibition.
    Koshimizu H; Leiter LM; Miyakawa T
    Mol Brain; 2012 Apr; 5():10. PubMed ID: 22463818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Muscarinic Acetylcholine Receptor Subtypes as Potential Drug Targets for the Treatment of Schizophrenia, Drug Abuse and Parkinson's Disease.
    Dencker D; Thomsen M; Wörtwein G; Weikop P; Cui Y; Jeon J; Wess J; Fink-Jensen A
    ACS Chem Neurosci; 2012; 3(2):80-89. PubMed ID: 22389751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic reduction of muscarinic M4 receptor modulates analgesic response and acoustic startle response in a mouse model of fragile X syndrome (FXS).
    Veeraragavan S; Graham D; Bui N; Yuva-Paylor LA; Wess J; Paylor R
    Behav Brain Res; 2012 Mar; 228(1):1-8. PubMed ID: 22123412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.